Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 2.05 | 1.50 | 1.50 | 0.70 | 0.28 | 0.81 | |||
Changes by years, y/y, % | -13% | -27% | 0% | -53% | -60% | -35.9% |
Arcutis Biotherapeutics. Debt/EBITDA
Arcutis Biotherapeutics. Debt/EBITDA, changes, %
Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 0.29 | 1.04 | 1.12 | 0.88 | 0.68 | 0.81 | ||
Changes by years, y/y, % | -59% | +147% | +166% | +317% | +624% | |||
Changes by quarters, q/q, % | +209% | +261% | +8% | -21% | -23% |